Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buddy Creech

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2024
Safety and Immunogenicity of an mRNA-1273 Booster in ChildrenVladimir Berthaud, C Buddy Creech, Christina A Rostad, et al.
Vaccine|November 30, 2025
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccinationSharon E Frey, Lindsey R Baden, Hana M El Sahly, et al.
JAMA|April 30, 2021
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021Isaac See, John R Su, Allison Lale, et al.
The New England Journal of Medicine|May 11, 2022
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of AgeC Buddy Creech, Evan Anderson, Vladimir Berthaud, et al.
Vaccine|March 19, 2025
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of ageTheresa E Hegmann, Emmanuel B Walter, Michael J Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 22, 2020
Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial DiseaseGetahun Abate, Jack T Stapleton, Nadine Rouphael, et al.
JAMA|January 25, 2022
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021Matthew E Oster, David K Shay, John R Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative ReviewSarah B Doernberg, Cesar A Arias, Deena R Altman, et al.
Plos One|June 2, 2015
Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin TherapySara L Van Driest, Tracy L McGregor, Digna R Velez Edwards, et al.
Vaccine|April 17, 2024
Overview of U.S. COVID-19 vaccine safety surveillance systemsJulianne Gee, Tom T Shimabukuro, John R Su, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2024
Safety and Immunogenicity of an mRNA-1273 Booster in ChildrenVladimir Berthaud, C Buddy Creech, Christina A Rostad, et al.
Vaccine|November 30, 2025
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccinationSharon E Frey, Lindsey R Baden, Hana M El Sahly, et al.
JAMA|April 30, 2021
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021Isaac See, John R Su, Allison Lale, et al.
The New England Journal of Medicine|May 11, 2022
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of AgeC Buddy Creech, Evan Anderson, Vladimir Berthaud, et al.
Vaccine|March 19, 2025
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of ageTheresa E Hegmann, Emmanuel B Walter, Michael J Smith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 22, 2020
Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial DiseaseGetahun Abate, Jack T Stapleton, Nadine Rouphael, et al.
JAMA|January 25, 2022
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021Matthew E Oster, David K Shay, John R Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative ReviewSarah B Doernberg, Cesar A Arias, Deena R Altman, et al.
Plos One|June 2, 2015
Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin TherapySara L Van Driest, Tracy L McGregor, Digna R Velez Edwards, et al.
Vaccine|April 17, 2024
Overview of U.S. COVID-19 vaccine safety surveillance systemsJulianne Gee, Tom T Shimabukuro, John R Su, et al.
Pageof 14